2021 annual financial data
Foghorn Therapeutics 2021 Operating cash flow
Foghorn Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -50,250,000 USD.
Operating income was -100,734,000 USD and net income was -101,320,000 USD.
Operating cash flow was -50,250,000 USD.
Get free Foghorn Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,319,000 USD
- Operating income
- -100,734,000 USD
- Net income
- -101,320,000 USD
- Operating cash flow
- -50,250,000 USD